Background The results from small clinical studies suggest that therapy with adult bone
marrow (BM)–derived cells (BMCs) reduces infarct size and improves left ventricular function
and perfusion. However, the effects of BMC transplantation in patients with ischemic heart
disease remains unclear. Methods We searched MEDLINE, EMBASE, Science Citation
Index, CINAHL (Cumulative Index to Nursing and Allied Health), and the Cochrane Central
Register of Controlled Trials (CENTRAL)(through July 2006) for randomized controlled trials …